E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.

Tobias Lange; Ursula Valentiner; Daniel Wicklein; Hanna Maar; Vera Labitzky; Ann-Kristin Brauns; Thomas Streichert; Benjamin Otto; Guido Sauter; Gerrit Wolters-Eisfeld; Kristoffer Riecken; Christian Bärnchen; Rainer Kiefmann; Valsamma Abraham; Horace M DeLisser; Timo Gemoll; Jens K Habermann; Udo Schumacher

doi:10.1200/jco.2016.34.15_suppl.e23010

E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.

Tobias Lange, Ursula Valentiner, Daniel Wicklein, Hanna Maar, Vera Labitzky, Ann-Kristin Brauns, Thomas Streichert, Benjamin Otto, Guido Sauter, Gerrit Wolters-Eisfeld, Kristoffer Riecken, Christian Bärnchen, Rainer Kiefmann, Valsamma Abraham, Horace M DeLisser, Timo Gemoll, Jens K Habermann, Udo Schumacher

Department of Surgery

Original language	German
Journal	Journal of Clinical Oncology
Volume	34
Issue number	15_suppl
Pages (from-to)	e23010-e23010
ISSN	0732-183X
DOIs	https://doi.org/10.1200/jco.2016.34.15_suppl.e23010
Publication status	Published - 06.09.2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 9 Industry, Innovation, and Infrastructure

Access to Document

10.1200/jco.2016.34.15_suppl.e23010

Cite this

Lange, T., Valentiner, U., Wicklein, D., Maar, H., Labitzky, V., Brauns, A.-K., Streichert, T., Otto, B., Sauter, G., Wolters-Eisfeld, G., Riecken, K., Bärnchen, C., Kiefmann, R., Abraham, V., DeLisser, H. M., Gemoll, T., Habermann, J. K., & Schumacher, U. (2018). E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition. Journal of Clinical Oncology, 34(15_suppl), e23010-e23010. https://doi.org/10.1200/jco.2016.34.15_suppl.e23010

@article{f384b52f485a43ff97354e29b412cbf6,

title = "E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.",

author = "Tobias Lange and Ursula Valentiner and Daniel Wicklein and Hanna Maar and Vera Labitzky and Ann-Kristin Brauns and Thomas Streichert and Benjamin Otto and Guido Sauter and Gerrit Wolters-Eisfeld and Kristoffer Riecken and Christian B{\"a}rnchen and Rainer Kiefmann and Valsamma Abraham and DeLisser, \{Horace M\} and Timo Gemoll and Habermann, \{Jens K\} and Udo Schumacher",

year = "2018",

month = sep,

day = "6",

doi = "10.1200/jco.2016.34.15\_suppl.e23010",

language = "Deutsch",

volume = "34",

pages = "e23010--e23010",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15\_suppl",

}

Lange, T, Valentiner, U, Wicklein, D, Maar, H, Labitzky, V, Brauns, A-K, Streichert, T, Otto, B, Sauter, G, Wolters-Eisfeld, G, Riecken, K, Bärnchen, C, Kiefmann, R, Abraham, V, DeLisser, HM, Gemoll, T, Habermann, JK & Schumacher, U 2018, 'E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.', Journal of Clinical Oncology, vol. 34, no. 15_suppl, pp. e23010-e23010. https://doi.org/10.1200/jco.2016.34.15_suppl.e23010

TY - JOUR

T1 - E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.

AU - Lange, Tobias

AU - Valentiner, Ursula

AU - Wicklein, Daniel

AU - Maar, Hanna

AU - Labitzky, Vera

AU - Brauns, Ann-Kristin

AU - Streichert, Thomas

AU - Otto, Benjamin

AU - Sauter, Guido

AU - Wolters-Eisfeld, Gerrit

AU - Riecken, Kristoffer

AU - Bärnchen, Christian

AU - Kiefmann, Rainer

AU - Abraham, Valsamma

AU - DeLisser, Horace M

AU - Gemoll, Timo

AU - Habermann, Jens K

AU - Schumacher, Udo

PY - 2018/9/6

Y1 - 2018/9/6

UR - http://www.mendeley.com/research/eselectin-ligand-binding-affinity-determine-antimetastatic-efficacy-proteasome-inhibition

U2 - 10.1200/jco.2016.34.15_suppl.e23010

DO - 10.1200/jco.2016.34.15_suppl.e23010

M3 - Zeitschriftenaufsätze

SN - 0732-183X

VL - 34

SP - e23010-e23010

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15_suppl

ER -

E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.

UN SDGs

Access to Document

Other files and links

Cite this